Search

everythinglearnresearchcommunity

for

Search:↓

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

New compounds were made that are promising for prostate cancer therapy.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Oxiconazole nitrate cream is effective and safe for treating various fungal skin infections.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

A quick method was developed to detect banned substances in urine for doping control.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.